相关实验视频
Updated: Jul 9, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.9K
一个最小化的测量方案用于预测HbA1c使用离散的自我监测血糖数据在4周内为2型糖尿病患者
Ang Li1, Xiang Li2, Zhanxiao Geng2
1Department of Endocrinology, Peking University First Hospital, Beijing, China.
Diabetes technology & therapeutics
|November 30, 2023
概括
预测2型糖尿病 (T2D) 患者的血红蛋白A1c (HbA1c) 现在使用最小的血糖数据更准确. 这项研究建立了一个最佳的,具有成本效益的监测方案,用于常规的血糖跟踪.
科学领域:
- 内分泌学和新陈代谢学
- 生物医学数据科学 生物医学数据科学
- 临床糖尿病管理 临床糖尿病管理
背景情况:
- 2型糖尿病 (T2D) 的管理需要定期监测血糖控制.
- 血红蛋白A1c (HbA1c) 提供了长期测量血糖水平的指标.
- 目前的监测策略可能是繁重和昂贵的.
研究的目的:
- 开发一种可靠的模型来预测T2D患者的HbA1c,使用最小的,不规则的血糖数据.
- 提出一个高效和具有成本效益的常规血糖监测方案.
- 提高HbA1c预测模型的准确性和稳定性.
主要方法:
- 利用了两个大型数据集 (2017-2022),其中包括2432名T2D患者,约420,000个不规则的血糖值和10,000个HbA1c值.
- 采用了规范化的极端学习机器,用于数据拟合和模型开发.
- 基于准确性 (MAE,RMSE,R值) 和成本效益的多个监测方案进行了比较.
主要成果:
- 最佳方案要求在过去四周内至少进行七次禁食和七次食后血糖值,以预测HbA1c.
- 实现了高预测准确度,R = 0.8029 (P < 0.001) 和MAE = 0.3181% (95% CI: 0.2666-0.3695%). 在这个过程中,R = 0.8029 (P < 0.001) 和MAE = 0.3181%.
- 与之前的研究相比,开发的模型显示出更高的准确性和稳定性,特别是在具有显著血糖波动的患者中.
结论:
- 已经建立了一个准确而强大的计算模型,用于预测T2D患者的HbA1c,使用有限的血糖数据自我监测.
- 这些发现为设计实用和科学血糖监测方案提供了新的,基于证据的参考.
- 这种方法为例行糖尿病护理提供了具有成本效益的策略,改善了患者管理和结果.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes: Management and Pharmacotherapy
289
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
289
Diabetes: Symptoms, Diagnosis, and Complications
554
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
554
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Hypoglycemia and Glucagon
272
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
272

